Literature DB >> 29772443

MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.

Jun Guo1, Ning Wen2, Sefei Yang3, Xiaohang Guan4, Song Cang4.   

Abstract

Increasing evidence indicates that microRNAs dysregulation contributes to the development and progression of various human cancers, including oral squamous cell carcinoma (OSCC). However, little is known about the potential role of microRNA-92a (miR-92a) in OSCC. Thus, the aim of this study was to investigate the effects of miR-92a expression on OSCC cell growth, apoptosis and tumorigenesis. Real-time quantitative polymerase chain reaction was used to detect the expression level of miR-92a in primary tumor tissues and OSCC cell lines. The effects of miR-92a on cell proliferation, cell cycle, apoptosis and tumorigenesis of OSCC cells were explored after miR-92a expression was increased or decreased in the UM1 and Tca-8113 cells, respectively. The 3'-untranslated region (3'-UTR) of FOXP1 combined with miR-92a was analyzed with dual-luciferase reporter assays. The level of miR-92a expression was significantly up-regulated in the OSCC tissues and cell lines. The up-regulation of miR-92a expression promoted UM1 cell proliferation, cell cycle progression in vitro and tumor growth in nude mice, but its expression reduction inhibited these processes and induced apoptosis in Tca-8113 cells. Additionally, miR-92a expression was inversely correlated with FOXP1 protein expression in the OSCC tissues and cell lines. Furthermore, FOXP1 was identified as a functional downstream target of miR-92a by directly targeting the 3'-UTR of FOXP1. These findings indicate that miR-92a may act as a tumor inducer in OSCC by suppressing FOXP1 expression, and it could serve as a potential therapeutic target for OSCC treatment.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell proliferation; FOXP1; MiR-92a; MicroRNAs; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29772443     DOI: 10.1016/j.biopha.2018.05.025

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Characteristics of circRNAs expression profiles in the piglets intestine induced by oxidative stress.

Authors:  Zhi-Xin Li; Wei Chen; Ming Qin; Li-Xue Wang; Yong-Qing Zeng
Journal:  Genes Genomics       Date:  2021-08-27       Impact factor: 1.839

2.  Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression.

Authors:  Dong-Yeon Nam; Je-Keun Rhee
Journal:  Biology (Basel)       Date:  2022-05-21

3.  ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma.

Authors:  Xiaolong Wang; Rui Hao; Fengjuan Wang; Fan Wang
Journal:  Cancer Manag Res       Date:  2020-08-13       Impact factor: 3.989

4.  Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.

Authors:  Ahmed Zaki; Amal Fawzy; Samia Y Akel; H Gamal; Reham A A Elshimy
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

5.  MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.

Authors:  Da Ni; Jiping Teng; Youshuang Cheng; Zhijun Zhu; Bufeng Zhuang; Zhiyin Yang
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

6.  MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xiaoying Li; Baosen Zhou
Journal:  Front Mol Biosci       Date:  2019-10-01

Review 7.  Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts.

Authors:  Li-Jie Li; Wei-Min Chang; Michael Hsiao
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.